Prior screening mammography linked to earlier stage at breast cancer diagnosis, lower breast cancer mortality.

Researchers sought to determine whether a pharmacist-led clinic for administering venetoclax would be effective for patients with CLL.

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.

With a 95% retention rate for nurse residents completing the program and a 100% 2-year post-hire retention rate, these initiatives ensure a stable and well-trained workforce.

The most common projected cancers in adults were lung cancer, colon cancer, leukemia, bladder cancer, and stomach cancer.

A team of researchers explain how navigation programs work, who benefits, and how to create a successful navigation program.

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

DB-1305/BNT325 was generally well tolerated and exhibited “very encouraging and durable antitumor activity in ovarian cancer patients,” said Maria Rubinstein, MD.

Researchers describe how they developed a program for home-based management of indwelling PICC to improve patient self-management.

Researchers sought to assess the impact of Medicaid coverage on diagnosis for pediatric patients and AYAs with lymphoma.

Current guidelines do not specify the ideal timing between standard TURBT, neoadjuvant chemotherapy, and radical cystectomy in patients with muscle-invasive bladder cancer.

(HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced genitourinary (GU) toxicity in patients ...